Predictors of steroid non-response and new approaches in severe alcoholic hepatitis
Shiv Kumar Sarin, Shvetank Sharma
Clin Mol Hepatol. 2020;26(4):639-651.   Published online 2020 Oct 1     DOI: https://doi.org/10.3350/cmh.2020.0196
Citations to this article as recorded by Crossref logo
Mesenchymal stem cells-based therapy in liver diseases
Heng-Tong Han, Wei-Lin Jin, Xun Li
Molecular Biomedicine.2022;[Epub]     CrossRef
Quercetin alleviates ethanolā€induced hepatic steatosis in L02 cells by activating TFEB translocation to compensate for inadequate autophagy
Xingtao Zhao, Xinyan Xue, Jing Wang, Shu Dai, Cheng Peng, Yunxia Li
Phytotherapy Research.2022;[Epub]     CrossRef
Patients with a History of Bariatric Surgery Are 8 Years Younger at Presentation with Severe Alcoholic Hepatitis
Lukas Van Melkebeke, Annelotte G. C. Broekhoven, Tessa Ostyn, Hannelie Korf, Minneke J. Coenraad, Roman Vangoitsenhoven, Bart Van der Schueren, Matthias Lannoo, Hannah Van Malenstein, Tania Roskams, Schalk van der Merwe, Frederik Nevens, Jef Verbeek
Obesity Surgery.2022;[Epub]     CrossRef
Can granulocyte colony stimulating factor (G-CSF) ameliorate acetaminophen-induced hepatotoxicity?
EA Ahmed, AM Abd-Eldayem, E Ahmed
Human & Experimental Toxicology.2021; 40(10): 1755.     CrossRef
Treatment of severe alcoholic hepatitis: A systematic review
Lukas Van Melkebeke, Hannelie Korf, Emmanuel A. Tsochatzis, Schalk van der Merwe, Frederik Nevens, Jef Verbeek
Current Opinion in Pharmacology.2021; 60: 91.     CrossRef